Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.

This content is provided by , which may be using cookies and other technologies. To show you this content, we need your permission to use cookies. You can use the buttons below to ...